Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV research hub

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

This study is testing a new medicine called Surovatamig for people with certain types of chronic leukaemia or lymphoma, specifically those with 'unmutated IGHV'. It aims to see if Surovatamig, given after initial treatment, is safe and helps keep the cancer in check.